Skip to content

Alexza Pharmaceuticals Inc.

CIK 0001344413

← back to feed
Revenue (TTM)
$5.07M
−62.0% YoY Q1 May 2016
Net Income (TTM)
−$21.65M
+44.5% YoY Q1 May 2016
EPS Diluted (TTM)
—
Q1 May 2016
Gross Margin
-193.7%
Q1 May 2016
Operating Margin
-691.8%
Q1 May 2016
Net Margin
-426.8%
Q1 May 2016
Free Cash Flow (TTM)
−$27.24M
Q1 May 2016
Cash
$4.5M
Q1 May 2016
Total Debt
$9.56M
Q1 May 2016
Shares Outstanding
21.75M sh
Q1 May 2016

Revenue & Net Income

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings